Search results
Results from the WOW.Com Content Network
The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
It is speculated that this is due to neurotoxic effects of cannabis interfering with critical brain development. [16] [17] Chronic use of cannabis during adolescence, a time when the brain is still developing, is correlated in the long term with lower IQ and cognitive deficits.
Weed affects your ability to make decisions, control emotions, remember important data, plan, organize and solve problems, a new study found, and that impact may last well past your initial high.
A growing body of research and numerous anecdotal reports link cannabis with several health benefits.
Substance use is also often associated with premature ageing, fertility complications, brain damage and a higher risk of infectious diseases due to a weakened immune system. [ 15 ] [ 16 ] Long-term use has been linked to personality changes such as depression, paranoia, anxiety which can be related to psychological disorders.
More and more states are legalizing marijuana for medical and/or recreational use. High blood pressure is a major risk factor for heart attack and stroke. Stage 1 hypertension is defined as a ...
For the treatment of the withdrawal/negative affect symptom domain of cannabis use disorder, medications may work by alleviating restlessness, irritable or depressed mood, anxiety, and insomnia. [58] Bupropion, which is a norepinephrine–dopamine reuptake inhibitor, has been studied for the treatment of withdrawal with largely poor results. [58]